ARTICLE | Clinical News
RegeneRx preclinical data
November 15, 2010 8:00 AM UTC
In a mouse model of dry eye syndrome, RGN-259 significantly reduced corneal staining, a measure of the surface defects following induction of DES, vs. vehicle-treated controls (p<0.03). RegeneRx plans...